It is interesting that the majority of the identified genetic mutations causing congenital or sporadic vascular malformations activate directly or indirectly either the RAS/MAPK or the PI3K/AKT/mTOR pathways [11]. The gene discussed is MTOR; the disease is vascular malformation.